Literature DB >> 22580911

Comparative in vitro efficacies of ethanol-, EDTA- and levofloxacin-based catheter lock solutions on eradication of Stenotrophomonas maltophilia biofilms.

Beatriz Passerini de Rossi1, Laureana Feldman1, María Saliba Pineda1, Carlos Vay2, Mirta Franco1.   

Abstract

The aim of this study was to compare the in vitro activity of ethanol, EDTA and levofloxacin (Levo), alone or in combination, on biofilms of Stenotrophomonas maltophilia recovered from patients with catheter-related bloodstream infections (CRBSIs) at a university hospital in Argentina. First, 24 and 48 h biofilms were formed in microtitre plates and challenged with 25 or 40 % ethanol for 1 h. Biofilms, of the 14 local isolates and from the reference strain K279a, were eradicated after both treatments as shown by plate counts and the regrowth technique. Second, 24 h biofilms of all isolates were established in silicone catheter segments and challenged with 25 or 40 % ethanol, Levo (2.5 mg ml(-1)), EDTA (30 mg ml(-1)), 25 % ethanol-EDTA or Levo-EDTA for 1, 3 and 24 h. Viable counts of biofilms treated for 1 h with 25 or 40 % ethanol or 25 % ethanol-EDTA were under the limit of detection. Killing of biofilms by Levo or Levo-EDTA was gradual and it was only after 24 h of treatment that no differences could be seen between the effects of these catheter lock solutions (CLSs) and those of ethanol (P>0.05). Levo-EDTA, in combination, did not act synergistically against biofilms. After 24 h of exposure, EDTA did not eradicate biofilms but reduced biofilm survival rates to 1-5 %. The effect of the different CLSs on biomass reduction, estimated by crystal violet staining, was highly dependent on the isolate, and the most effective agents were 25 and 40 % ethanol. Our results suggest that when used as a CLS for short periods, ethanol at low concentrations, alone or in combination with a chelator, can decontaminate the line from S. maltophilia in cases of CRBSI and help, in conjunction with systemic antibiotics, in the retention of precious vascular catheters.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22580911     DOI: 10.1099/jmm.0.039743-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  6 in total

1.  Treatment of Infected Cardiac Implantable Electronic Devices.

Authors:  Abdulla Fakhro; Faryan Jalalabadi; Rodger H Brown; Shayan A Izaddoost
Journal:  Semin Plast Surg       Date:  2016-05       Impact factor: 2.314

Review 2.  Antimicrobial lock therapy in central-line associated bloodstream infections: a systematic review.

Authors:  Matteo Vassallo; Brigitte Dunais; Pierre-Marie Roger
Journal:  Infection       Date:  2015-02-06       Impact factor: 3.553

3.  Adjunctive management of central line-associated bloodstream infections with 70% ethanol-lock therapy.

Authors:  David W Kubiak; Erin T Gilmore; Mary W Buckley; Robert Lynch; Francisco M Marty; Sophia Koo
Journal:  J Antimicrob Chemother       Date:  2014-02-12       Impact factor: 5.790

4.  In Vitro and In Vivo Activity of a Novel Catheter Lock Solution against Bacterial and Fungal Biofilms.

Authors:  J Chandra; L Long; N Isham; P K Mukherjee; G DiSciullo; K Appelt; M A Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

5.  Iron is a signal for Stenotrophomonas maltophilia biofilm formation, oxidative stress response, OMPs expression, and virulence.

Authors:  Carlos A García; Eliana S Alcaraz; Mirta A Franco; Beatriz N Passerini de Rossi
Journal:  Front Microbiol       Date:  2015-09-04       Impact factor: 5.640

6.  Anti-biofilm and Anti-Virulence Efficacy of Celastrol Against Stenotrophomonas maltophilia.

Authors:  Hye-Rim Kim; Dongsup Lee; Yong-Bin Eom
Journal:  Int J Med Sci       Date:  2018-03-28       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.